TITLE

Desensitisation of neutrophil responses by systemic interleukin 8 in cystic fibrosis

AUTHOR(S)
Dai, Y; Dean, T P; Church, M K; Warner, J O; Shute, J K
PUB. DATE
September 1994
SOURCE
Thorax;Sep1994, Vol. 49 Issue 9, p867
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66032080

 

Related Articles

  • Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum. Mackerness, K. J.; Jenkins, G. R.; Bush, A.; Jose, P. J. // Thorax;Jul2008, Vol. 63 Issue 7, p614 

    Background: Most patients with cystic fibrosis (CF) die of respiratory failure due to chronic infection and destructive neutrophilic inflammation. Objective: To identify potential therapeutic targets by characterising the neutrophil stimulating mediators in the CF airway. Methods: Spontaneously...

  • The Role of Sphingolipids and Ceramide in Pulmonary Inflammation in Cystic Fibrosis. Becker, Katrin Anne; Riethmüller, Joachim; Yang Zhang; Gulbins, Erich // Open Respiratory Medicine Journal;2010, Vol. 4, p39 

    Sphingolipids and in particular ceramide have been shown to be critically involved in the response to many receptor-mediated, but also receptor-independent, mainly stress stimuli. Recent studies demonstrate that ceramide plays an important role in the pathogenesis of cystic fibrosis, a...

  • Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice. Legssyer, Rachida; Huaux, François; Lebacq, Jean; Delos, Monique; Marbaix, Etienne; Lebecque, Patrick; Lison, Dominique; Scholte, Bob J.; Wallemacq, Pierre; Leal, Teresinha // Respiratory Research;2006, Vol. 7, p134 

    Background: Inflammation plays a critical role in lung disease development and progression in cystic fibrosis. Azithromycin is used for the treatment of cystic fibrosis lung disease, although its mechanisms of action are poorly understood. We tested the hypothesis that azithromycin modulates...

  • Vehicles for gene therapy. Wilson, James M. // Nature;10/21/1993, Vol. 365 Issue 6448, p691 

    Discusses a report on a trial of cystic fibrosis gene therapy in humans. Use of recombinant adenovirus; Identification of the gene responsible for cystic fibrosis.

  • A morphometric study of mucins and small airway plugging in cystic fibrosis. Burgel, Pierre-Régis; Montani, David; Danel, Claire; Dusser, Daniel J.; Nadel, Jay A. // Thorax;Feb2007, Vol. 62 Issue 2, p153 

    Rationale: Little knowledge exists on structural changes and plugging in small airways in cystic fibrosis. Objective: To characterise the extent of plugging and contribution of secreted mucins to the plugs. Methods: Small airways in patients with cystic fibrosis at transplantation (n = 18) were...

  • Lung inflammation: Disarming neutrophils in cystic fibrosis. Leavy, Olive // Nature Reviews Immunology;Jan2008, Vol. 8 Issue 1, p8 

    The article presents a medical research in Great Britain on reducing neutrophils in cystic fibrosis. It is said that the accumulation of neutrophils and high concentrations of the chemokine interleukin-8 (IL-8) in the airways is a characteristic feature of chronic lung diseases. However, further...

  • Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Hartl, Dominik; Latzin, Philipp; Hordijk, Peter; Marcos, Veronica; Rudolph, Carsten; Woischnik, Markus; Krauss-Etschmann, Susanne; Koller, Barbara; Reinhardt, Dietrich; Roscher, Adelbert A; Roos, Dirk; Griese, Matthias // Nature Medicine;Dec2007, Vol. 13 Issue 12, p1423 

    Interleukin-8 (IL-8) activates neutrophils via the chemokine receptors CXCR1 and CXCR2. However, the airways of individuals with cystic fibrosis are frequently colonized by bacterial pathogens, despite the presence of large numbers of neutrophils and IL-8. Here we show that IL-8 promotes...

  • Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. Vandivier, R. William; Fadok, Valerie A.; Hoffmann, Peter R.; Bratton, Donna L.; Penvari, Churee; Brown, Kevin K.; Brain, Joseph D.; Accurso, Frank J.; Henson, Peter M. // Journal of Clinical Investigation;3/1/2002, Vol. 109 Issue 5, p661 

    Cystic fibrosis is characterized by an early and sustained influx of inflammatory cells into the airways and by release of proteases. Resolution of inflammation is normally associated with the orderly removal of dying apoptotic inflammatory cells through cell recognition receptors, such as the...

  • Response to the Letter Entitled 'Comments Concerning Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis'. Antus, Balazs; Barta, Imre // Lung;Oct2015, Vol. 193 Issue 5, p861 

    A response from the author of the article "Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis" in the 2015 issue is presented.

  • Comments Concerning 'Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis'. Khoubnasabjafari, Maryam; Ansarin, Khalil; Jouyban, Abolghasem // Lung;Oct2015, Vol. 193 Issue 5, p867 

    A letter to the editor is presented in response to the article "Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis" by B. Antus and colleagues in the 2015 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics